Lupin Limited

BSE : 500257 | NSE : LUPIN

Industry : Pharma Drugs | ISIN : INE326A01037 | FreeFloat : 55.00% | FnO : Yes | LotSize : 850


Intellectual Capital (IC)-3,763.10
Net Worth (NW)12,764.69
Intrinsic Worth (IW)9,001.59
Market Cap (MC)45,659.43
Economic Value Added-167.04
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)-41.80%
IC Gross Margin (EBITDA/IC)-62.05%
IC Net Margin (NPT/IC)3.82%
Knowledge Turnover (Sales/IC)-4.23
Market to Intrinsic Value (MC/IW)5.07

As OfIntrinsic ValueMarket Price
30 Sep 2020Rs. 198.61Rs. 1,007.40
22 Jan 2021 - Rs. 1,079.25
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : NoSell10 DMA : Rs. 1,079.03BuyHold
KB > 50% : No50 DMA : Rs. 971.50
0 < M2IV < 1 : NoVol-Price trend : Rising

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Dec-17
C
3975.62
4004.04
717.35
437.00
383.00
222.23
195.89
Mar-18
C
4033.83
4178.75
-662.10
-934.93
-940.78
-777.60
-783.54
Jun-18
C
3855.93
4040.13
711.86
452.88
384.16
203.02
-67.47
Sep-18
C
3951.06
4181.74
780.67
515.18
441.36
268.45
242.73
Dec-18
C
4504.85
4548.29
454.97
175.21
95.44
-152.36
-130.06
Mar-19
C
4406.32
4492.82
962.51
681.73
596.21
296.37
336.59
Jun-19
C
4418.38
4490.59
933.42
616.33
530.71
303.05
377.60
Sep-19
C
4359.55
4492.92
318.79
-2.68
-89.14
-127.07
-214.23
Dec-19
C
3716.09
3769.27
235.01
-18.22
-106.82
-835.00
-891.98
Mar-20
C
3845.74
4054.34
818.00
603.74
496.36
391.29
-148.95
Jun-20
C
3527.86
3571.14
531.92
317.28
273.02
106.90
183.54
Sep-20
C
3835.00
3859.96
606.56
393.83
360.21
211.02
239.61
* C - Consolidated, S - Standalone